The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Thanks for your useless piece of information.
Down 15% already.
Looks like positive news
Maybe, you have missed understood me, If you are defending your 8.06 footprint "plus 11.7%" there is no need too! I believe thats how the website was intended to be used. The footprint brought the company to everyones attention this morning whilst leaving a valuable piece of information that can be viewed in the future. Its all the other garbage that is frustrating, it appears to me that a lot of the newer members are treating the site as a general chat forum which just fills up the board. Anyway, until the situation calms down a bit, which I'm sure it will, I shall only leave "RNS out", "Article relevent here" or "up/down" footprints. GL and keep up the good work.
These boards used to be informative and relatively unbiased but since NRK collapsed it appears to have been dragged down to the www.iii.co.uk level. Unbiased information can be found in lse boards but to sift through the garbage is soul destroying! Like you I saw the possibility of ACG and used my better judgement to return a tidy profit, at the same time DFD turned up trumps as well. If only people would report the information in an unbiased way, it would bring the pleasure back into reading these boards. I have refrained from listing the RNS content in the last week as most of the boards I have been watching are full of junk, ramping and deramping!
An RNS has arrived
RNS out.
RNS out
The Board of Henderson Morley plc ("Henderson Morley" or "the Company"), the AIM listed drug discovery company, is pleased to update the market with progress regarding its treatment of Feline Herpes Virus (FHV) conjunctivitis. The Company is continuing a clinical trial to examine the safety and efficacy of ICVT ophthalmic drops. This study is now underway in Germany, and several veterinary centres have been recruited. For more details, checkout the RNS.
The Board of Inspicio notes the recent rise in the Company's share price and confirms it has recently received approaches from interested parties which may or may not lead to an offer being made for the Company. There is no certainty that any offer will be forthcoming.
The Director's confidence with Cyprotex's core operations continued to build during the third quarter of 2007. The Group enters the final three months of its year on an optimistic note. Historically the final quarter has been the strongest period of Cyprotex's financial year. Moreover, management is pleased to confirm that its customer base has continued to expand rapidly. Included within the high number of new MSA (Master Services Agreements) recently signed, and taking the Group's 'active customer list' beyond 150 pharmaceutical and biotech companies, are several international majors. Strict confidentiality agreements preclude Cyprotex from naming individual clients, but the company can now confirm it is currently contracted to work for six out of the world's 'top ten' global pharmaceutical companies. The scale and visibility that strong working relationships with such partners are capable of providing, is key to proving Cyprotex's business plan. The management is pleased to report an exceptional level of repeat business, while also being asked to tenders for more long-term contract work as well as project specific collaborations. Cyprotex presently holds an adequate cash resource whilst also retaining a significant, unused banking facility. Based on current momentum, management sees the opportunity for modest cash generation to expand this 'cushion' still further during the final three months of the 2007.
certainly got lucky on this one I was not expecting the rise. If I was in your shoes I would take the profit unless you know something! I wont have the time to do any research until the weekend but I am not expecting to find anything surprising. Good luck with whatever you decide.
up 8.8%
chan, been following last couple of months, possibilities here but would like some good news before splashing the cash. Either August or September saw major disruption by floods. as you suggest more research needed.
Ahead of the Announcement of the results for the six months ended Sept 30th 2007, the Board of Directors of WorkPlace Systems International plc (WorkPlace) provides the following update on trading. Under new CEO Barney Quinn who was appointed in November 2006, WorkPlace has continued its recovery with both revenue growth and a return to profitability in the first half-year plus a performance which is ahead of expectations. This has been achieved through contribution from new contracts, increased revenue from existing clients and the continued effect of last year's cost reductions. WorkPlace continues to invest in new software product development and in North America. Since the end of the half-year, a Global Framework Agreement has been signed with the retail division of a large energy company and work has already started in two countries as part of this agreement. This new contract together with a strong underlying pipeline and ongoing revenue from the existing client base provides good visibility of projected WorkPlace revenues for the second half of this financial year. The Board is pleased with the performance in the first-half and is cautiously optimistic for the full year's results. The Interim Results for the six months to 30 September 2007 will be announced on 12th December 2007.
up 16%
still climbing, anybody have any thoughts on future prospects.
Lot of selling the last few days, looks like mm's want some buyers.
Competition Commission clears proposed acquisition of Vernons Football Pools Sportech PLC (the "Company"), the UK's leading football gaming business, notes the announcement that the Company's proposed acquisition of Vernons Football Pools has been cleared by the Competition Commission. The Competition Commission, which published its final decision earlier today, has confirmed that the proposed acquisition will not lead to a substantial lessening of competition. The Company will now seek to conclude its discussions with Ladbrokes PLC (the owners of Vernons) and a further announcement will be made in due course. Ian Penrose, Chief Executive, said "We are delighted that at the end of this lengthy and detailed process, we have received clearance from the Competition Commission to proceed with the acquisition of Vernons. We will now look to conclude our negotiations with Ladbrokes."
The Board of UK Commercial Property Trust Limited (the "Company") refers to the prospectus (the "Prospectus") published by the Company on launch in September 2006. The Prospectus stated that, if the market price of a Share in the Company was more than five per cent. below the published net asset value of a Share for a continuous period of 90 dealing days or more, the Directors would convene an extraordinary general meeting to consider an ordinary resolution for the continuation of the Company. The Company announces that, as at close of business yesterday, the Shares had traded at more than a five per cent. discount to their net asset value for 90 continuous dealing days. In accordance with the intention stated in the Prospectus, the Directors therefore intend to convene an extraordinary general meeting to consider a resolution (the "Resolution") to approve the continuation of the Company. See RNS for further details.